How cervical screening is changing in the UK

Written by: Mr Jullien Brady
Published: | Updated: 12/04/2023
Edited by: Lisa Heffernan

The UK is about to change how they screen for cervical cancer. Clinics will begin to look for the presence of high-risk HPV as the primary test for cervical screening. The test will still be taken in the same way, so the process will be exactly the same for women. If the HPV virus is not identified, the smear part of the test will not be analysed.

We asked consultant gynaecologist, Mr Jullien Brady, why these changes are being made and how many women actually go to their first smear appointment.

Why are these changes being made?

When cervical screening for cancer was first introduced in the UK, no one fully understood that HPV was the primary cause. HPV testing is more accurate but still requires a smear test to identify women at risk, as the presence of the HPV infection may be only temporary and may not necessarily indicate that there is a problem. The smear test involves taking a small sample of cells from the cervix to check for the presence of abnormal cells.


What will happen now when women receive their results?

If smear test results are normal, the woman will continue to have routine screenings. Abnormal results will require a woman to attend for a colposcopy examination to identify and potentially monitor and treat any abnormal changes.

A colposcopy looks at the cervix using a device called a colposcope. It’s similar to a smear test but takes a little longer. A speculum is inserted into the vagina to visualise the cervix and sometimes a biopsy may be carried out where a small sample of tissue is taken to be analysed further.


What percentage of women invited for their smear actually attend?

Sadly over one million women in the UK have never had a smear test and one million women are more than 12 months late for their most recent test.


How could this be improved?

Many women find the actual process of having a smear done difficult for lots of reasons. One of the most exciting recent innovations by companies such as GynaeCheck (Check4Cancer) is the ability of a woman to self-sample for the HPV virus. This can be done in the privacy and comfort of her own home with no need for a speculum examination. As such, they can avoid the need for a traditional smear test on average nine times out of 10.


If you have any questions regarding cervical cancer screening or you’d like to make an appointment with Mr Brady, please head to his Top Doctors profile.

By Mr Jullien Brady
Obstetrics & gynaecology

Mr Jullien Brady is a leading consultant gynaecologist based in Bedford at BMI The Manor Hospital in the Bedford and Northampton areas. He is considered an international authority on cervical screening and colposcopy, giving frequent lectures and talks about them. He is also an expert in treating heavy periods, menopause, pelvic pain, and ovarian cysts. Mr Brady has run his own clinic since 2003 at which he offers HPV vaccination, cervical smear tests, and an extensive range of gynaecological services and operative procedures.

Mr Brady completed his initial medical degree at the University of London in 1997, after which he did his postgraduate training in the London area. His interest in pre-cancerous changes of the cervix began in medical school, which has gone on to shape his entire medical career. He was appointed as a Fellow of the Royal College of Obstetricians and Gynaecologists in 2016 to recognise his contributions to this speciality, in the areas of colposcopy and cervical screening.

Outside of his clinics, Mr Brady has dedicated his time to the education in his field. He has earned an international lecturer and clinical reputation in the quality assurance aspects of colposcopy during a cervical screen service; this privilege reflects Mr Brady's passion to his work. He continues to teach postgraduates on the respected Teale Fenning Medical Education courses.

In addition, Mr Brady takes on roles in public associations. He is currently a member of the main committee of the British Society for Colposcopy and Cervical Pathology (BSCCP), which is the national governing body for colposcopy. Mr Brady also continues to be a professional clinical advisor for colposcopy for Public Health England.

View Profile

Overall assessment of their patients

  • Related procedures
  • Platelet-rich plasma
    Sexually transmitted infections (STIs)
    Cosmetic Consulting
    Breast reconstruction
    Congenital malformations
    Sexual dysfunction
    Erectile dysfunction
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.